Full Breakdown
DEA Moves to Temporarily Schedule Synthetic Kratom Compounds as Schedule I
7/3/2026, 4:28:21 AM
Temporary Schedule I Classification of 7-OH and Related Substances
The DEA issued a draft notice to temporarily place synthetic 7-hydroxymitragynine (7-OH) and three related chemicals—mitragynine pseudoindoxyl (MP), MGM-15, MGM-16—into Schedule I. Products with >0.05 % 7-OH by dry weight (or >1 mg) would be illegal for two years, with a possible one-year extension.
Background & Context: Kratom and Synthetic 7-OH
Kratom (Mitragyna speciosa) is a Southeast Asian plant whose leaves contain only trace 7-OH. Manufacturers now sell synthetic 7-OH and derivatives at much higher concentrations, marketed as gummies, capsules, powders, tablets, liquid shots, and strips in gas stations, convenience stores, smoke shops, and online.
Key Figures & Stakeholders
DEA Administrator Terrance Cole issued the notice. HHS Secretary Robert F. Kennedy Jr. endorsed it. President Donald Trump previously backed natural kratom. Botanic Tonics founder JW Ross and the nonprofit Shatterproof have also commented.
Data & Statistics: Thresholds and Overdose Cases
The DEA threshold is >0.05 % dry weight or >1 mg 7-OH. Los Angeles County health officials reported six fatal overdoses, ages 18–40, with alcohol in most cases. Synthetic 7-OH appears in dozens of retail outlets nationwide.
Why It Matters: Public-Health Risks
Authorities cite tolerance, dependence, addiction, respiratory depression, and unpredictable effects, especially when 7-OH is mixed with alcohol or other drugs. Flavored gummies raise concerns about youth exposure, linking the ban to opioid-crisis mitigation.
Official Statements & Responses
The DEA called 7-OH an “imminent threat to safety” and said the scheduling targets products, not botanical kratom. HHS Secretary Kennedy called them “dangerous opioids that fuel addiction and put American lives at risk.” Trump administration pledged to use authority to stop products, while the FDA warns kratom has no approved medical use and poses health risks.
On-the-Ground Reports: California Overdose Cluster
California officials noted the six Los Angeles County deaths involved otherwise healthy adults and that alcohol co-occurrence was common. State alerts warn that inconsistent dosing in unregulated 7-OH products raises accidental overdose risk.
Conflicting Reports & Gaps
Sources agree synthetic 7-OH is riskier than natural kratom, but nationwide usage data and total overdose counts are limited. No organized opposition to the temporary scheduling appears in the sources.
Verbatim Quotes
- “I commend the DEA for taking decisive action to address these addictive and harmful substances,” — Robert F. Kennedy Jr., HHS Secretary
- “This is an important and long-overdue step toward addressing the rapid proliferation of highly potent, chemically modified kratom-related products that have outpaced existing regulatory safeguards,” — Shatterproof, nonprofit
- “ "Temporarily scheduling these substances underscores the emphasis this Administration has put on the safety, health and well-being of the American people," according to Cole.” — Terrance Cole, DEA Administrator
- “According to the DEA, synthetic 7-OH products have become more common in recent years and are sold online, at gas stations, convenience stores and smoke shops.” — DEA statement
What’s Next: Enforcement Timeline and Potential Extension
The temporary scheduling will take effect 30 days after publication, authorizing criminal, civil, and administrative enforcement. The DEA will monitor compliance and may extend the ban for a third year if the threat persists. State agencies, including California’s health department, plan continued alerts and local enforcement.
